Amylyx Pharmaceuticals logo

Associate Director, Site Start-Up

Amylyx Pharmaceuticals

Cambridge, MARemotePosted 1 day ago$182,000 - $205,000/year
Full TimeDirector & AboveClinical DevelopmentPharmaceutical
Original posting ↗

Summary

Reporting to the Sr. Director of Global Site Services, the Associate Director, Site Start-Up will partner with Clinical Operations Leadership to lead the operational implementation and delivery of site activation activities. This is a hands-on role that combines process development with direct leadership of activation delivery and issue resolution. This role will integrate into study teams across the portfolio, and help define the processes, templates, systems, and controls for in-house site start-up, with ownership of day-to-day oversight and execution of activation delivery across the portfolio, maintaining continuity for ongoing studies while the function is established.

Job description

The Opportunity

Reporting to the Sr. Director of Global Site Services, the Associate Director, Site Start-Up will partner with Clinical Operations Leadership to lead the operational implementation and delivery of site activation activities. This is a hands-on role that combines process development with direct leadership of activation delivery and issue resolution. This role will integrate into study teams across the portfolio, and help define the processes, templates, systems, and controls for in-house site start-up, with ownership of day-to-day oversight and execution of activation delivery across the portfolio, maintaining continuity for ongoing studies while the function is established.

Responsibilities

  • In partnership with Sr. Director, Global Site Services, assists in implementing processes, procedures, and systems, to enable effective insourcing of clinical operations work in compliance with ICH GCP, data integrity, inspection readiness, and quality delivery.
  • Responsible for training, management and oversight of internal staff and/or Functional Service Provider (FSP) resources supporting study start-up.
  • Acts as Subject Matter Expert (SME) in the development of requirements for CTMS and SSU technology processes and platforms to be implemented.
  • Works cross-functionally to develop potential site lists from evidence-based sources.
  • Pilots new processes on early trials, captures lessons learned, and scales refined approaches across the portfolio.
  • Confirms that applicable activation prerequisites — including milestones dates, required site initiation and training — are completed, documented, and approved by the designated functional owners.
  • Coordinates formal site activation authorization in accordance with company procedures.
  • Manages escalation and resolution of start-up issues across sites and studies, keeping management and study leadership informed of risks to activation commitments.
  • Ensures activation milestones, statuses, and dates are accurate, auditable, and reflected in portfolio reporting, with sound rationale captured for date changes.
  • Assesses established baseline enrollment projections against actual enrollment activities—creating and implementing action plans for lagging site enrollment or late activations.
  • Responsible for the “first pass” review of any redlined Clinical Trial Agreement (CTA) received from sites, and manages escalations to legal until fully executed
  • Responsible for the review, development, and tracking of site budgets—ensuring consistency and fitment with established fair market values.
  • Tracks the utilization and allocation of assigned FSP resources across study assignments.

Requirements

  • BA/BS degree with at least 8 years of CRO, biotech/pharmaceutical industry experience preferred in a Clinical Operations environment.
  • Expert level knowledge of global Feasibility and Site Start-Up operations and requirements
  • Expert level knowledge of GCP, ICH, FDA and other regulations that govern the conduct of clinical trials, with direct experience in Inspection Readiness preparation.
  • Ability to work cross-functionally to satisfy requirements

Preferred Qualifications

  • People management and training experience.
  • Past experience working at a clinical trial site a plus.
  • Thrives in a fast-paced environment.
  • Direct experience with identifying the need for process improvement and creating process to support goals and requirements.

Requirements

  • BA/BS degree
  • At least 8 years of CRO, biotech/pharmaceutical industry experience in a Clinical Operations environment
  • Expert level knowledge of global Feasibility and Site Start-Up operations and requirements
  • Expert level knowledge of GCP, ICH, FDA and other regulations governing clinical trials
  • Direct experience in Inspection Readiness preparation
  • Ability to work cross-functionally

Benefits

  • Performance-based bonuses
  • Equity awards
  • Health insurance
  • Comprehensive benefits package

Company overview

Amylyx Pharmaceuticals is a clinical-stage pharmaceutical company based in Cambridge, Massachusetts, founded in 2013 by co-CEOs Josh Cohen and Justin Klee. The company specializes in developing novel therapies for neurodegenerative diseases with high unmet medical needs, with a particular focus on amyotrophic lateral sclerosis (ALS), Wolfram syndrome, and post-bariatric hypoglycemia. Amylyx's lead investigational therapy, AMX0035, received FDA approval for ALS treatment under the brand name RELYVRIO in September 2022. The company employs a rigorous scientific approach to target multiple pathological pathways in neurodegeneration, with additional pipeline candidates including avexitide for metabolic disorders and AMX0114, an antisense oligonucleotide targeting calpain-2 for ALS. With a team of 201-500 employees, Amylyx combines therapeutic development expertise with commercialization capabilities to address some of medicine's most challenging conditions.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.